Dukes Iain D. 4
4 · Lomond Therapeutics Holdings, Inc. · Filed Nov 5, 2024
Insider Transaction Report
Form 4
Dukes Iain D.
DirectorCEO and Chairman
Transactions
- Award
Stock Option (Right to Buy)
2024-11-01+2,096,667→ 2,096,667 totalExercise: $1.30Exp: 2034-09-18→ Common Stock (2,096,667 underlying)
Footnotes (1)
- [F1]The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting monthly after November 1, 2024, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.